Vera Therapeutics, Inc.
VERA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$152,148 | -$95,990 | -$89,056 | -$32,609 |
| Dep. & Amort. | $105 | -$4,086 | -$846 | $176 |
| Deferred Tax | $0 | $0 | $0 | -$1,799 |
| Stock-Based Comp. | $20,802 | $11,493 | $8,887 | $3,012 |
| Change in WC | $2,660 | -$5,869 | $6,747 | $3,511 |
| Other Non-Cash | -$6,098 | $2,271 | $6,672 | $4,001 |
| Operating Cash Flow | -$134,679 | -$92,181 | -$67,596 | -$23,708 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$972 | -$63 | -$62 | $0 |
| Net Acquisitions | $0 | $0 | $70 | $796 |
| Inv. Purchases | -$711,987 | -$224,930 | -$148,490 | $0 |
| Inv. Sales/Matur. | $278,958 | $185,562 | $78,000 | $0 |
| Other Inv. Act. | $8,972 | $0 | -$70 | -$5,000 |
| Investing Cash Flow | -$425,029 | -$39,431 | -$70,552 | -$4,204 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $24,741 | $19,816 | $4,921 |
| Stock Issued | $632,537 | $115,000 | $86,131 | $51,176 |
| Stock Repurch. | -$13 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$25,851 | -$6,200 | -$4,014 | -$2,215 |
| Financing Cash Flow | $606,673 | $133,541 | $101,933 | $53,882 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $46,965 | $1,929 | -$36,215 | $25,970 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $45,681 | $43,752 | $79,967 | $53,997 |
| End Cash | $92,646 | $45,681 | $43,752 | $79,967 |
| Free Cash Flow | -$135,651 | -$92,244 | -$67,658 | -$23,708 |